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Abstract 
Chemical investigation of a methanolic extract of leaves from Araucaria bidwillii 
(Araucariaceae) from Egypt afforded four new labdane diterpenoidal metabolites (1-4) together 
with one known diterpene, 7-oxocallitrisic acid (5), two triterpenoidal metabolites, 2-O-acetyl-
11-keto-boswellic acid (6) and β-sitosterol-3-O-glucopyranoside (7), phloretic acid (8), and two 
methylated bisflavonoids, agathisflavone-4’,7,7”-trimethyl ether (9) and cupressuflavone-
4’,7,7”-trimethyl ether (10). The new metabolites 1–4 were unambiguously identified by 
applying extensive 1D and 2D NMR spectroscopic studies as well as HRESIMS. The relative 
and absolute configurations of 1–4 were determined using ROESY and the modified Mosher’s 
method, respectively. All isolated compounds were assessed for their antimicrobial, 
antitubercular and cytotoxic activities. Among the tested compounds, the new labdane diterpenes 
1–4 revealed significant cytotoxic activity against mouse lymphoma L5178Y cell line with IC50 
values ranging from 1.4 to 12.9 µM, respectively. 
 
 
Keywords: Araucaria bidwillii, labdane diterpene, antibacterial, cytotoxicity, TDDFT-ECD 
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1. Introduction: 
Medicinal plants have been used in almost all cultures as a pivotal source of medicine for 
treatment and management of various human diseases. The traditional use of medicinal plants in 
developing countries, as a normative basis for the maintenance of good health, is widely 
observed. However, an increasing reliance on medicinal plants in the industrialized societies has 
been traced as well to develop several new drugs and chemotherapeutics in addition to the 
treatment of minor ailments. 
Araucaria bidwillii is a plant belonging to family Araucariaceae with so diverse 
economical and agricultural uses in addition to be a traditional remedy for the treatment of 
amenorrhea (Aslam et al., 2013; Chen et al., 2011). The genus Araucaria has been distinguished 
by several reports in literature as a rich source of labdane diterpenes (Aslam et al., 2013; Chen et 
al., 2011; Noma et al., 1982; Caputo et al., 1976; Caputo et al., 1974) and bisflavonoids such as 
7-O-methylcupressuflavone, 7,7''-di-O-methylagathisflavone, 7-O-methylagathisflavone, 4,7'''-
di-O-methylagathisflavone and 7,7''di-O-methylcupressuflavone (Rahman et al., 1968). Labdane 
diterpenes are known to possess antialgal, antimicrobial and antiproliferative activities (Chen et 
al., 2011; Tanaka et al., 2000; Dimas et al., 1998; Jung et al., 1998). 
In the current study, we report four new labdane diterpenoidal metabolites (1-4) (Figure 1) 
together with six known compounds including 7-oxocallitrisic acid (5) (Lee et al., 1994), two 
triterpenoidal metabolites namely, 2-O-acetyl-11-keto-boswellic acid (6) (Belsner et al., 2003; 
Csuk et al., 2015) and β-sitosterol-3-O-glucopyranoside (7) (Seo et al., 1978), in addition to 
phloretic acid (8) (Tanagornmeatar et al., 2014), two methylated bisflavonoids, agathisflavone-
4’,7,7”-trimethyl ether (9) (Ofman et al., 1995) and cupressuflavone-4’,7,7”-trimethyl ether (10) 
(Inatomi et al., 2005; Ofman et al., 1995). 
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Figure 1. Chemical structures of the isolated compounds of Araucaria bidwillii 
 
2. Results and Discussion 
Compound 1 was isolated as an amorphous yellowish white solid. HRESIMS of 1 revealed a 
pseudomolecular ion peak at m/z 473.2662 [M+Na]+ (calcd for 473.2668 C29H38NaO4) indicating 
the existence of eleven degrees of unsaturation whereas its UV spectrum revealed absorption 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
5 
 
maxima at 232 and 309 nm. 13C NMR of 1 (Table 1) exhibited 29 different carbons divided into 
seven quaternary carbons including one carbonyl at δC 169.4; four olefinic quaternary carbons at 
δC 161.3, 151.4, 148.5 and 127.2 together with two aliphatic quaternary carbons at δC 40.0 and 
38.5 ppm. Additionally, 13C NMR spectrum of compound 1 showed 22 carbon resonances 
including aliphatic primary, secondary and tertiary carbons, olefinic tertiary and aromatic 
carbons. Based on 1H and 13C NMR of 1 (Table 1), compound 1 was suggested to be an ester 
derivative of labda-13(16),14-diene-19-ol diterpene as revealed by close similarity of its spectral 
data with labdane diterpenoidal esters isolated from Juniperus thurifera (San Feliciano et al., 
1988) and Chamaecyparis formosensis (Lin et al., 1999). 1H NMR, 1H–1H COSY and HMQC 
spectra of 1 (Table 1, see supplementary data) revealed proton resonances at δH 6.32 (1H, d, J= 
16.0 Hz), 7.59 (1H, d, J= 16.0 Hz), 6.81 (2H, d, J= 8.7 Hz) and 7.47 (2H, d, J= 8.7 Hz) ppm 
ascribed for olefinic carbons at δC 115.2 (C-2’), 146.5 (C-3’), 116.8 (C-6’ and C-8’) and 131.2 
(C5’ and C-9’) ppm, respectively, indicative for an (E)-p-hydroxycinnamoyl (= coumaroyl) 
moiety together with UV absorption maxima (λmax) at 232 and 309 nm (Lin et al., 1999). 
In addition, compound (1) displayed a hydroxy group at C-7 and an exocyclic methylene 
moiety at C-8 which was previously reported in labdane diterpenoids isolated from A. 
cunninghamii (Chen et al., 2011) and from Nicotiana raimondii (Noma et al, 1982). The 
exocyclic methylene moiety displayed proton resonances at δH 4.75 (1H, br s) and 5.27 (1H, br s) 
ppm which were correlated to the same carbon resonating at δC 104.1 ppm as shown through the 
HMQC experiment (see supplementary data). The position of the exocylic methylene moiety was 
unambiguously confirmed through further 2D NMR experiments such as HMBC (Figure 2a) 
which disclosed long range correlations with two tertiary aliphatic carbons at δC 74.8 and 55.0 
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assigned for C-7 and C-9, respectively, together with a correlation to an olefinic quaternary 
carbon at δC 151.4 ascribed to C-8. 
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Table 1. NMR Data of compounds (1-4). 
# 1 2 3 4 
δH
a
 
(multi, J value in Hz) δCb δHa (multi, J value in Hz) δCb δHc (multi, J value in Hz) δCd δHe (multi, J value in Hz) δCf 
1 1.07 (1H, m) 
1.76 (1H, m) 
39.9, CH2 1.09 (1H, m) 
1.77 (1H, m) 
40.0, CH2 1.00 (1H, m) 
1.77 (1H, m) 
38.9, CH2 1.02 (1H, m) 
1.72 (1H, m) 
38.5, CH2 
2 0.88 (1H, m) 
1.53 (1H, m) 
20.0, CH2 0.85 (1H, m) 
1.52 (1H, m) 
20.0, CH2 1.52 (1H, m) 
1.60 (1H, m) 
19.1, CH2 0.87 (1H, m) 
1.52 (1H, m) 
19.4, CH2 
3 1.12 (1H, m) 
1.78 (1H, m) 
37.7, CH2 1.04 (1H, m) 
1.67 (1H, m) 
37.4, CH2 1.06 (1H, m) 
1.78 (1H, m) 
36.7, CH2 1.00 (1H, m) 
1.52 (1H, m) 
36.7, CH2 
4  38.5, C  38.3, C  37.6, C  36.4, C 
5 1.63 (1H, m) 55.8, CH 1.60 (1H, m) 55.9, CH 1.60 (1H, m) 54.8, CH 1.56 (1H, m) 53.6, CH 
6 1.39 (1H, m) 
2.21 (1H, dd, 9.8, 5.2) 
35.0, CH2 1.34 (1H, m) 
2.14 (1H, dd, 9.8, 5.2) 
34.8, CH2 1.37 (1H, m) 
2.27 (1H, dd, 9.8, 5.2) 
34.4, CH2 1.28 (1H, m) 
2.20 (1H, m) 
34.1, CH2 
7 3.88 (1H, m) 74.8, CH 3.87 (1H, dd, 9.8, 5.2) 74.8, CH 3.96 (1H, dd, 9.8, 5.2) 74.3, CH 3.96 (1H, dd, 9.8, 5.2) 74.1, CH 
8  151.4, C  151.4, C  150.1, C  154.6, C 
9 1.39 (1H, m) 55.0, CH 1.32 (1H, m) 55.0, CH 1.33 (1H, m) 53.9, CH 1.28 (1H, m) 54.4, CH 
10  40.0, C  40.0, C  39.3, C  38.9, C 
11 1.63 (1H, m) 
1.77 (1H, m) 
23.4, CH2 1.59 (1H, m) 
1.69 (1H, m) 
23.4, CH2 1.60 (1H, m) 
1.73 (1H, m) 
22.2, CH2 1.60 (1H, m) 
1.73 (1H, m) 
21.8, CH2 
12 2.05 (1H, m) 
2.40 (1H, m) 
31.0, CH2 2.03 (1H, m) 
2.37 (1H, m) 
31.0, CH2 2.00 (1H, m) 
2.38 (1H, m) 
30.0, CH2 1.99 (1H, dd, 15.1, 9.1) 
2.36 (1H, m) 
30.0, CH2 
13  148.5, C  148.5, C  148.0, C  147.3, C 
14 6.38 (1H, dd, 17.6, 11.0) 140.2, CH 6.39 (1H, dd, 17.6, 10.9) 140.2, CH 6.37 (1H, dd, 17.6, 11.0) 139.1, CH 6.36 (1H, dd, 17.6, 10.9) 139.7, CH 
15 5.05 (1H, d, 11.0) 
5.22 (1H, d, 17.6) 
113.6, 
CH2 
5.06 (1H, d, 10.9) 
5.23 (1H, d, 17.6) 
113.6, CH2 5.05 (1H, d, 11.0) 
5.21 (1H, d, 17.6) 
113.4, CH2 5.05 (1H, d, 10.9) 
5.20 (1H, d, 17.6) 
113.2. CH2 
16 4.97 (1H, br s) 116.2, 4.98 (1H, br s) 116.1, CH2 4.97 (1H, br s) 115.8, CH2 4.96 (1H, br s) 115.6, CH2 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
8 
 
5.00 (1H, br s) CH2 5.02 (1H, br s) 5.01 (1H, br s) 5.00 (1H, br s) 
17 4.75 (1H, br s) 
5.27 (1H, br s) 
104.1, 
CH2 
4.74 (1H, br s) 
5.27 (1H, br s) 
104.1, CH2 4.97 (1H, br s) 
5.23 (1H, br s) 
103.5, CH2 4.75 (1H, br s) 
5.20 (1H, br s) 
103.1, CH2 
18 1.07 (3H, s) 28.1, CH3 0.98 (3H, s) 28.0, CH3 1.06 (3H, s) 27.9, CH3 0.96 (3H, s) 27.6, CH3 
19 3.99 (1H, d, 11.0) 
4.38 (1H, d, 11.0) 
67.9, CH2 3.92 (1H, d, 11.0) 
4.33 (1H, d, 11.0) 
67.6, CH2 3.96 (1H, d, 11.4) 
4.36 (1H, d, 11.4) 
66.8, CH2 3.89 (1H, d, 11.2) 
4.27 (1H, d, 11.2) 
66.6, CH2 
20 0.73 (3H, s) 15.7, CH3 0.74 (3H, s) 15.7, CH3 0.72 (3H, s) 15.4, CH3 0.69 (3H, s) 15.4, CH3 
1’  169.4, C  168.7, C  167.6, C  167.6, C 
2’ 6.32 (1H, d, 16.0) 115.2, CH 5.79 (1H, d, 12.7) 117.0, CH 6.29 (1H, d, 16.0) 115.9, CH 5.82 (1H, d, 12.7) 116.8, CH 
3’ 7.59 (1H, d, 16.0) 146.5, CH 6.88 (1H, d, 12.7) 144.6, CH 7.61 (1H, d, 16.0) 144.9, CH 6.84 (1H, d, 12.7) 143.2, CH 
4’  127.2, C  127.3, C  127.3, C  127.6, C 
5’,9’ 7.47 (2H, d, 8.7) 131.2, CH 7.59 (2H, d, 8.7) 133.3, CH 7.48 (2H, d, 8.7) 130.0, CH 7.66 (2H, d, 8.7) 132.0, CH 
6’,8’ 6.81 (2H, d, 8.7) 116.8, CH 6.76 (2H, d, 8.7) 115.9, CH 6.90 (2H, d, 8.7) 114.5, CH 6.87 (2H, d, 8.7) 113.5, CH 
7’  161.3, C  160.0, C  161.5, C  160.5, C 
7’-OCH3     3.84 (3H, s) 55.5, CH3 3.82 (3H, s) 56.6, CH3 
a 1H NMR measured in MeOH-d4 at 600 MHz. b 13C NMR measured in MeOH-d4 at 150 MHz. c 1H NMR measured in CHCl3-d at 400 
MHz. d 13C NMR measured in CHCl3-d at 100 MHz. e 1H NMR measured in CHCl3-d at 600 MHz. f 1H NMR measured in CHCl3-d at 
150 MHz. 
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The hydroxyl group at C-7 revealed proton resonance at δH 3.88 (1H, m) and carbon 
resonance at δC 74.8 ppm as confirmed by HMQC experiment. The exact linkage of this 
hydroxyl group at C-7 was proven based upon HMBC experiments (Figure 2a) which revealed 
key long range correlations between the exocyclic methylene protons at δH 4.75 (1H, br s) and 
5.27 (1H, br s) attached at C-8 and methylene protons at δH 1.39 (1H, m) and 2.21 (1H, dd, J= 
9.8, 5.2 Hz) ppm assigned for C-6 to C-7 at δC 74.8 ppm. Moreover, a long range HMBC 
correlation was found between proton resonance at δH 3.88 (1H, m) at C-7 and carbon resonance 
at δC 35.0 ppm assigned for C-6. Based upon the aforementioned data, compound (1) was 
confirmed to be the new 7-hydroxy-labda-8(17),13(16),14-trien-19-yl-(E)-coumarate. 
For establishing the relative and absolute configurations of 1, a ROESY experiment 
(Figure 2b) and the modified Mosher’s reaction (Table 2) were conducted, respectively. Results 
of Mosher’s reactions of the hydroxyl group at C-7 unambiguously determined its absolute 
configuration as S, whereas the ROESY experiment (Figure 2b) revealed clear correlations 
between H-7 at δH 3.88 (1H, m) with two multiplet proton resonances at δH 1.39 and δH 1.63 ppm 
assigned for H-9 and H-5 in addition to a singlet methyl group at δH 1.07 ppm assigned for 
methyl group at C-4, respectively. ROESY experiment of 1 also revealed clear correlations 
between hydroxymethylene protons at δH 3.99 (1H, d, J = 11.0 Hz) and 4.38 (1H, d, J = 11.0 Hz) 
ppm, a singlet methyl group at δH 0.73 ppm and a methylene group at δH 1.63 (1H, m) and 1.77 
(1H, m) ppm assigned for C-19, Me-20 and C-11, respectively. Based on the results obtained 
from Mosher’s reaction and ROESY experiment, the absolute configuration of compound 1 was 
unambiguously determined to be 4S,5R,7S,9R,10S in accordance with the previously reported 
absolute configurations of chiral centers at C-5, C-9 and C-10 (Maldonado et al., 2015). 
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Table 2. Chemical shift differences between the (S)-MTPA and (R)-MTPA esters of compound 
(1). 
position 
Chemical shift (δH, in C5D5N, 600 MHz) in ∆ 
∆(S) – δ(R) 1 (S)-MTPA ester (R)-MTPA ester 
6a 2.5435 2.5524 2.5379 +0.0145 
6b 1.7721 1.8583 1.7144 +0.1439 
17a 5.8916 5.7080 5.7304 -0.0224 
17b 4.9525 4.6990 4.7082 -0.0092 
 
 
Figure 2.  Key 1H-1H COSY, HMBC and ROESY correlations in compound (1). 
 
Compound 2, isolated as a yellowish white amorphous powder, revealed a 
pseudomolecular ion peak at m/z 473.2662 [M+Na]+ (calcd for 473.2668 C29H38NaO4) and UV 
absorption maxima (λmax) at 231 and 307 nm similar to compound (1). In spite of the close 
similarity in spectral data of compounds 1 and 2 (Table 1), the latter displayed proton resonances 
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at δH 5.79 (1H, d, J = 12.7 Hz), 6.88 (1H, d, J = 12.7 Hz), 6.76 (2H, d, J = 8.7 Hz) and 7.59 (2H, 
d, J = 8.7 Hz) ppm attributable to (Z)-coumarate (Lin et al., 1999). The coupling constant of 12.7 
Hz for the two olefinic protons in 2 was smaller than that in the E-isomer 1 where the coupling 
constant is 16.0 Hz. Apart from this difference between 1 and 2, both revealed a close 
resemblance with regard to their 1D and 2D NMR spectral data including 1H–1H COSY, HMQC 
and HMBC experiments (Table 1, see supplementary data). Based on the biosynthetic 
relationship and having comparable optical rotation values, it was deduced that 1 and 2 share the 
same relative and absolute configurations which were supported by similar optical rotation 
values. In conclusion, compound 2 was unambiguously confirmed to be the new 7-hydroxy-
labda-8(17),13(16),14-trien-19-yl-(Z)-coumarate which featured the absolute configuration 
4S,5R,7S,9R,10S. 
The molecular formula of compound 3 was established to be C30H40O4 based on the 
existence of a pseudomolecular ion peak at m/z 482.3265 [M+NH4]+ (calcd for 482.3270 
C30H44NO4) indicating a difference of 14 amu compared to compounds 1 and 2. 1H NMR, 1H–1H 
COSY and HMQC spectra of 3 were similar to those of 1 (Table 1, see supplementary data) 
revealing proton resonances at δH 6.29 (1H, d, J = 16.0 Hz), 7.61 (1H, d, J = 16.0 Hz), 6.90 (2H, 
d, J = 8.7 Hz) and 7.48 (2H, d, J = 8.7 Hz) ppm ascribed for aromatic carbons at δC 115.9 (C-2’), 
144.9 (C-3’), 114.5 (C-6’ and C-8’) and 130.0 (C5’ and C-9’) ppm, respectively, thus confirming 
the existence of an (E)-coumaroyl moiety in compound 3. This was confirmed through the UV 
spectrum displaying maximal absorption peaks (λmax) at 231 and 308 nm (Lin et al., 1999).  1H 
and 13C NMR spectral data of 3 (Table 1) disclosed that it comprises an additional singlet 
oxygenated methyl group at δH 3.84 ppm which was correlated to a primary oxygenated carbon 
resonance at δC 55.5 ppm as revealed by HMQC spectrum. In addition, HMBC spectrum of 3 
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revealed a clear long range correlation between the methoxy group at δH 3.84 ppm and a 
quaternary aromatic carbon at δC 161.5 ppm indicating that the 14 amu difference is due to the 
methylation of phenolic hydroxyl group in the coumarate moiety. Apart from this difference, 1D 
and 2D NMR spectra including HMQC, HMBC and ROESY experiments of 3 closely resembled 
those of 1 in addition to 3 exhibiting a similar optical rotation value compared to that of 1. Based 
on this close similarity in relative configuration and biosynthetic relationship between 
compounds 1 and 3, the latter was unambiguously concluded to be 7-hydroxy-labda-
8(17),13(16),14-trien-19-yl-7’-O-methyl-(E)-coumarate exhibiting probably the same absolute 
configuration 4S,5R,7S,9R,10S as elucidated for 1. 
The HRESIMS of compound 4 revealed pseudomolecular ion peaks at m/z 482.3265 
[M+NH4]+ (calcd for 482.3270 C30H44NO4) and 487.2819 [M+Na]+ (calcd for 487.2824 
C30H40NaO4) indicating the molecular formula C30H40O4 which is identical to that of 3. 1H NMR 
spectral data of 4 exhibited proton resonances similar to 2 in particular with regard to the two 
olefinic protons at δH 5.82 (1H, d, J = 12.7 Hz), 6.84 (1H, d, J = 12.7 Hz), 6.87 (2H, d, J = 8.7 
Hz) and 7.66 (2H, d, J = 8.7 Hz) ppm which correlated to carbon resonances at δC 116.8 (C-2’), 
143.2 (C-3’), 113.5 (C-6’ and C-8’) and 132.0 (C5’ and C-9’) ppm, respectively, as 
unambiguously disclosed by the HMQC experiment. In addition, the UV spectrum of 4 displayed 
absorption maxima (λmax) at 232 and 305 nm which together with NMR spectral data indicated 
the presence of (Z)-coumarate moiety as a part of the structure (Lin et al., 1999). The coupling 
constant (J value) of 12.7 Hz for the two olefinic protons in 4 was smaller than that for the E-
isomers 1 and 3 where the coupling constants amounted to 16.0 Hz. 1H NMR spectral data of 4 
(Table 1) revealed an additional singlet oxygenated methyl group at δH 3.82 ppm in comparison 
to 2 which was correlated to a primary oxygenated carbon resonance at δC 56.6 ppm as revealed 
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by the HMQC spectrum. In addition, the HMBC spectrum of 4 revealed a clear long range 
correlation between the methoxy group at δH 3.82 ppm and a quaternary aromatic carbon at δC 
160.5 ppm indicating that the 14 amu difference is due to the methylation of phenolic hydroxyl 
group in the (Z)-coumarate moiety. Apart from this structural difference, 1D and 2D NMR 
spectra including HMQC, HMBC and ROESY experiments of 4 (Table 1, see supplementary 
data) closely resembled those of 2 in addition to similar optical rotation values that were 
observed for both compounds. Based on this close similarity in relative configuration and 
biosynthetic relationship compound 4 was unambiguously identified as 7-hydroxy-labda-
8(17),13(16),14-trien-19-yl-7’-O-methyl-(Z)-coumarate for which the same absolute 
configuration 4S,5R,7S,9R,10S is proposed. 
Compound 9 and 10 are heterodimeric biaryl natural products with 6,8’- and 8,8-linked 
flavone residues. Due to the substitution pattern and the position of the linkage, the biaryl 
systems of 9 and 10 have a high rotational energy barrier, which gives rise to atropisomerism 
(Bringmann et al., 2005). The specific rotation value and ECD spectra clearly indicated the 
presence of axial chirality, since both compounds contain no further chirality elements. The 
solution TDDFT-ECD calculation protocol has been efficiently utilized for the determination of 
axial chirality in biaryl natural products having hindered rotation (Rönsberg et al, 2013; Bara et 
al., 2013; Ola et al., 2014; Wu et al., 2015). Compound 9 is the 4’,7,7”-trimethyl ether derivative 
of agathisflavone, the natural biaryl component of Schinus terebinthifolius Raddi 
(Anacardiaceae), the absolute configuration of which was studied by the combination of various 
chiroptical methods (ECD, VCD and ORD) and (aS) absolute configuration (positive ωC5-C6-C8''-
C8a'' torsional angle) was assigned to the (−)-enantiomer (Covington et al., 2016). The ECD 
spectrum of compound 9  (Figure 3) had an oppositely signed pattern of Cotton effects (CEs) 
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compared to those of (−)-agathisflavone and an approximately 30 nm red shift of the 
corresponding CEs was also observed in acetonitrile.  
 
Figure 3. Experimental ECD spectrum of (+)-9 in MeCN compared with the Boltzmann-
weighted PBE0/TZVP ECD spectrum of (aS)-9 computed for the B97D/TZVP PCM/MeCN 
conformers. Bars represent the rotational strength values of the lowest-energy conformer. 
 
These data suggested that compound 9 had negative ωC5-C6-C8''-C8a'' torsional angle, opposite 
to that of (−)-agathisflavone, which however is also denoted by (aS) axial chirality, since the 
different substitution pattern alters the priority order. In order to test the applicability of our 
solution TDDFT-ECD protocol for biaryl natural products on the axial chirality of 9 and confirm 
its absolute configuration, ECD calculations of 9 were carried out (Pescitelli and Bruhn, 2016; 
Mándi et al., 2015). MMFF conformational search resulted in 136 conformers [with (aR) and 
(aS) axial chirality] in a 21 kJ/mol energy window. Conformers with negative ωC5-C6-C8''-C8a'' 
torsional angles [(aS) axial chirality] (Figure 4) were selected and reoptimized at the B3LYP/6-
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31G(d) in vacuo and the B97D/TZVP (Grimme, 2006; Sun et al., 2013) PCM/MeCN levels of 
theory.  
 
Figure 4. Structures and populations of the low-energy B97D/TZVP PCM/MeCN conformers 
(≥1%) of (aS)-9. 
 
ECD spectra computed for the low-energy (≥ 1%) conformers at various levels gave 
moderate to good agreement with the experimental spectrum of 9 allowing elucidation of the 
absolute configuration as (aS). By analyzing the compouted ECD spectra of the individual 
conformers, it turned out that the 340 and 260 nm ECD transitions are sensitive to both the biaryl 
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and the flavone (ωC3,C2,C1’,C2’) torsional angles. For the (aS) enantiomer, the low-energy 
conformers of 9 have an ωC5-C6-C8''-C8a'' torsional angle of either ca. −67° or ca. −107° 
(B97D/TZVP PCM/MeCN values). Furthermore, among the low-energy conformers, there were 
geometries with both positive and negative ωC3,C2,C1’,C2’ flavone torsional angles, which resulted 
in inversion of 340 and 260 nm CE (conformers E and H in Figure 5). Since substitution pattern 
of related molecules can alter both torsional angles, these transitions are not recommended for 
comparison to elucidate absolute configuration of agathisflavone derivatives when simple ECD 
correlation is applied. (−)-Agathisflavone and (+)-9 represent an example for chiral switching 
(Ebrahim et al., 2012; Zhang et al., 2015) of natural products when related natural derivatives are 
produced with opposite absolute configuration in different organisms. 
 
Figure 5. Experimental ECD spectrum of 9 in MeCN compared with the PBE0/TZVP ECD 
spectrum of conformers A, E and H of (aS)-9. Level of optimization: B97D/TZVP PCM/MeCN 
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Compound 10, the 8,8’-linked heterodimeric flavone biaryl derivative, had positive CE at 
357 nm and negative one at 322 nm in the ECD spectrum, which allowed the assignment of axial 
chirality as (aR) on the basis of the ECD spectrum of the related cupressuflavone 4’-O-β-D-
glucopyranosides (Inatomi et al., 2005). 
All isolated compounds were assessed for their antiproliferative activity(ies) against the 
mouse lymphoma (L5178Y) cell line using the in vitro cytotoxicity (MTT) assay and kahalalide 
F as a standard antiproliferative agent. Results (Table 3) revealed that among the four new 
labdane derivatives (1–4), compounds 1 and 2 revealed IC50 values of 2.22 and 1.42 µM, 
respectively. Both compounds are thus more potent than the standard drug kahalalide F with an 
IC50 value of 4.30 µM. 
 
Table 3. Cytotoxic activity of isolated compounds against mouse lymphoma L5178Y cell line. 
Compound L5178Y % Growth inhibition 
(10 µg/mL) 
EC50 in µM 
1 100 2.22 
2 100 1.42 
3 65 n.a. 
4 22 12.9 
5 94 >30 
Kahalalide F  4.30 
n.a.: not active. 
 
However, their respective methylated derivatives (3 and 4) exhibited moderate to no 
activity. These results suggest preliminary structure activity relationships (SAR) such as i) the 
configuration of the olefinic double bond of coumarate moiety does not significantly affect the 
cytotoxicity, ii) although methylation of the phenolic hydroxyl group does increase the 
lipophilicity which in turn increases its cellular uptake and bioactivity, compounds (3 and 4) 
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showed moderate or no activity compared to the non-methylated metabolites (1 and 2) 
presumably being due to steric hindrance leading to decreased binding to the yet unknown target 
receptors. 
Experimental section 
2.1. General experimental procedures 
Optical rotation was determined using a Perkin-Elmer-241 MC polarimeter. Mass spectrometry 
was measured on a LC-MS HP1100 Agilent Finnigan LCQ Deca XP Thermoquest whereas high-
resolution mass spectra (HRESIMS) were recorded on FTHRMS-Orbitrap (Thermo Finnigan) 
mass spectrometer. Analytical HPLC measurements were conducted on Dionex Ultimate 3000 
LC system coupled with a photodiode array detector (UVD340S), using detection channels at 
235, 254, 280 and 340 nm wavelengths. Ready-made separation columns (125 × 4 mm, L × ID), 
prefilled with Eurospher-10C18 (Knauer, Germany), were used implementing a gradient elution 
as follows, (MeOH, 0.01% HCOOH in H2O): 0 min, 10% MeOH; 5 min, 10% MeOH; 35 min, 
100% MeOH; 45 min, 100% MeOH, with a flow rate of 1 mL/min. Preparative HPLC separation 
was accomplished using a RP-HPLC system of LaChrom-Merk Hitachi (pump: L7100 and UV 
detector L7400; column: Eurospher 100C18, 300 × 8 mm, Knauer, Germany) with a flow rate of 
5.0 mL/min. Routine normal phase column chromatography was performed using Merck MN 
silica gel 60 M (0.04-0.063 mm) or Sephadex LH-20 as stationary phases. 1D (1H and 13C NMR) 
and 2D NMR (chemical shifts in ppm) spectra were measured by Bruker AVANCE DMX 600 
and AVANCE HD III 400 MHz NMR spectrometer (Switzerland) using methanol-d4 and 
chloroform-d solvents (Sigma Aldrich, Germany). ECD spectra were recorded on a J-810 
spectropolarimeter. Ready-made TLC plates precoated with silica gel 60 F254 (Merck, Darmstadt, 
Germany) were used for analytical purposes followed by detection under UV light at 254 and 
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365 nm wavelengths or after spraying with anisaldehyde and vanillin sulfuric acid spray 
reagents. Solvents used during the experiments were distilled before being used. Spectroscopic 
and deuterated grade solvents were used for spectroscopic and NMR measurements, 
respectively. 
2.2. Plant material 
Fresh leaves (7 kg) of A. bidwillii were collected at the Zoo Garden, Giza, Egypt, in January 
2015 and authenticated by Mrs. Therease Labib, consultant at Orman Botanical Garden and 
National Gene Bank, Giza, Egypt. A voucher specimen was deposited at Department of 
Pharmacognosy, Faculty of Pharmacy, Ain-Shams University given a code PHG-P-AB192. 
2.3. Extraction, isolation and purification 
Air-dried grounded leaves were extracted with methanol then evaporated till dryness yielding a 
solid residue of 313 g which was subjected to liquid-liquid fractionation between its aqueous 
dispersion (1.0 L) and petroleum ether (Pet. Ether, 3.0 L), ethyl acetate (EtOAc, 8.0 L), and 
butanol (n-BuOH, 8.0 L), each at room temperature to afford different fractions weighing 0.71, 
21.0 g and 56.0 g, respectively. From EtOAc extract about 10 g were fractionated over an open 
column packed with silica gel (250 g) as adsorbent. The elution process started with petroleum 
ether and then ethyl acetate was added gradually to increase the polarity of the eluent till 
reaching 100% ethyl acetate. Next dichloromethane and methanol in different ratios till reaching 
100% methanol were used to elute the column. Finally, the column was washed with acetone 
(100%). The elution process was inspected under UV light. Thirty fractions (500 mL each) were 
collected and monitored by TLC on silica gel plates. The TLC was examined under UV light and 
sprayed with vanillin sulphuric reagent. Similar fractions were pooled together and dried to give 
24 subfractions (A–X). 
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Fraction D (330 mg) eluted by Pet. Ether:EtOAc (8:2) was further purified by preparative 
HPLC resulting in the isolation and identification of compounds 3 (0.7 mg) and 4 (1.0 mg). 
Fraction F (350 mg) eluted with Pet. Ether:EtOAc (8:2) was further purified by preparative 
HPLC resulting in the isolation and identification of compounds 1 (6.6 mg) and 2 (6.9 mg), 
whereas fraction G (240 mg) eluted by Pet. Ether:EtOAc (3:2) was subjected to preparative 
HPLC for further purification yielding compounds 5 (2.8 mg) and 6 (5.6 mg). Fractions I and J 
(390 mg) also eluted by Pet. Ether:EtOAc (3:2) were also purified using preparative HPLC 
yielding compounds 8 (6.1 mg), 9 (2.3 mg) and 10 (8.3 mg). Fraction N (300 mg) eluted by 
100% EtOAc yielded compound 7 (1.2 mg) by crystallization. 
2.3.1. 7-Hydroxy-labda-8(17),13(16),14-trien-19-yl-(E)-coumarate (1). Yellowish white solid; 
	[α]

 +4.0 (c 0.70, MeOH); UV (MeOH) λmax: 232 and 309 nm; 1H and 13C NNR data see Table 
1; HRESIMS [M+Na]+ m/z 473.2662 (calcd for 473.2668 C29H38NaO4). 
2.3.2. 7-Hydroxy-labda-8(17),13(16),14-trien-19-yl-(Z)-coumarate (2). Yellowish white 
amorphous powder; 	[α] +17.5 (c 0.70, MeOH); UV (MeOH) λmax: 231 and 307 nm; 1H and 
13C NNR data see Table 1; HRESIMS [M+Na]+ m/z 473.2662 (calcd for 473.2668 C29H38NaO4). 
2.3.3. 7-Hydroxy-labda-8(17),13(16),14-trien-19-yl-7’-O-methyl-(E)-coumarate (3). 
Amorphous off-white solid; 
 
[α]

 +7.5 (c 0.70, MeOH); UV (MeOH) λmax: 231 and 308 nm; 1H 
and 13C NNR data see Table 1; HRESIMS [M+NH4]+ m/z 482.3265 (calcd for 482.3270 
C30H44NO4). 
2.3.4. 7-Hydroxy-labda-8(17),13(16),14-trien-19-yl-7’-O-methyl-(Z)-coumarate (4). Off-white 
amorphous powder; 
 
[α]

 +25.5 (c 0.70, MeOH); UV (MeOH) λmax: 232 and 305 nm; 1H and 
13C NNR data see Table 1; HRESIMS [M+NH4]+ m/z 482.3265 (calcd for 482.3270 C30H44NO4) 
and [M+Na]+ m/z 487.2819 (calcd for 487.2824 C30H40NaO4). 
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2.3.5. Agathisflavone-4’,7,7”-trimethyl ether (9). Yellow amorphous powder; 
 
[α]

 +33.0 (c 
0.60, MeOH); UV (MeOH) λmax: 206, 220, 272 and 328 nm; ECD (MeCN, λ [nm] (∆ε), c 0.172 
mM): 344 (+0.76), 306 (-1.96), 292 (-1.94), 262 (+2.01), 246sh (+0.77), 233 (–1.19), 217sh 
(+0.72), 205 (+2.13); 1H NMR data (Ofman et al., 1995); HRESIMS [M+H]+ m/z 581.1442 
(calcd for 581.1448 C33H25NO10). 
2.3.6. Cupressuflavone-4’,7,7”-trimethyl ether (10). Yellow amorphous powder; 
 
[α]

 -63.4 (c 
0.30, MeOH); UV (MeOH) λmax: 206, 225, 272 and 340 nm; ECD (MeCN, λ [nm] (∆ε), c 0.172 
mM): 357 (+4.07), 322 (-9.55), 305sh (-4.45), 267 (+3.60), 243 (+0.62), 226 (+1.58), 215 (-
0.37), 207 (+2.11); 1H NNR data (Inatomi et al., 2005; Ofman et al., 1995); HRESIMS [M+H]+ 
m/z 581.1442 (calcd for 581.1448 C33H25NO10). 
2.4. Mosher’s reaction 
Chiral derivatization was conducted following the convenient Mosher ester method as previously 
described in the literature (Su et al., 2002). The tested compounds (2 × 1 mg each) were 
transferred into clean dry NMR tubes under a N2 gas stream. The samples (1 mg) were dissolved 
in deuterated pyridine (0.5 mL), and both (R)- and (S)-α-methoxy-α-
(trifluoromethyl)phenylacetic (MTPA) acid chloride were added separately into the NMR tubes, 
immediately under a N2 gas stream. The reagent was added in the ration of 0.14 mM reagent to 
0.10 mM of the compound (Dale and Mosher, 1973). Careful shaking of the NMR tubes was 
performed to assure thorough mixing of the samples and MTPA chloride. The reaction NMR 
tubes were kept at room temperature and monitored by 1H NMR spectroscopy until the reaction 
was complete. 1H–1H COSY spectra were measured to confirm the assignment of the signals. 
2.5. Cytotoxicity (MTT) assay 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
22 
 
Antiproliferative activity was assessed against mouse lymphoma (L5178Y) cell line, using a 
microplate 3-(4,5-dimethythiazole-2yl)-2,5-diphenyl-tetrazolium bromide (MTT) assay as 
previously described (Ashour et al., 2006). All experiments were carried out in triplicate and 
repeated thrice. The cytotoxic depsipeptide kahalalide F (IC50 = 4.3 µM) was used as a positive 
control and a medium containing 0.1% EGMME-DMSO was used as a negative control. 
2.6. Computational Section 
Mixed torsional/low mode conformational searches were carried out by means of the 
Macromodel 9.9.223 (MarcoModel, 2012) software using Merck Molecular Force Field (MMFF) 
with implicit solvent model for CHCl3 applying a 21 kJ/mol energy window. Geometry 
optimizations [B3LYP/6-31G(d) in vacuo and B97D/TZVP (Grimme, 2006; Sun et al., 2013) 
with PCM solvent model for MeCN] and TDDFT calculations were performed with Gaussian 09 
using various functionals (B3LYP, BH&HLYP and PBE0) and TZVP basis set (Frisch et al., 
2010). ECD spectra were generated as the sum of Gaussians with 3000 cm–1 half-height width 
(corresponding to c.a. 20 nm at 260 nm), using dipole-velocity computed rotational strengths 
(Stephens and Harada, 2010). Boltzmann distributions were estimated from the ZPVE-corrected 
B3LYP/6-31G(d) energies in the gas-phase calculations and from the B97D/TZVP energies in 
the solvated ones. The MOLEKEL software package was used for visualization of the results 
(Marcomodel, 2012). 
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